losartan/hydrochlorothiazide aurobindo 100 mg/12.5 mg film-coated tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 12.5 mg losartan potassium 100 mg - agents acting on the renin-angiotensin system
losartan/hydrochlorothiazide aurobindo 100 mg/25 mg film-coated tablets
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - hydrochlorothiazide, losartan potassium - film-coated tablet - hydrochlorothiazide 25 mg losartan potassium 100 mg - agents acting on the renin-angiotensin system
losartan 50mg / hydrochlorothiazide 12.5mg tablets
accord-uk ltd - losartan potassium; hydrochlorothiazide - oral tablet - 50mg ; 12.5mg
losartan 100mg / hydrochlorothiazide 12.5mg tablets
accord-uk ltd - losartan potassium; hydrochlorothiazide - oral tablet - 100mg ; 12.5mg
losartan 50mg / hydrochlorothiazide 12.5mg tablets
lupin healthcare (uk) ltd - losartan potassium; hydrochlorothiazide - oral tablet - 50mg ; 12.5mg
losartan 50mg / hydrochlorothiazide 12.5mg tablets
milpharm ltd - losartan potassium; hydrochlorothiazide - oral tablet - 50mg ; 12.5mg
mykrox tablets- metolazone tablets tablet
celltech pharmaceuticals, inc. - metolazone (unii: tz7v40x7vx) (metolazone - unii:tz7v40x7vx) - tablet - 500 ug - mykrox tablets are indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. mykrox tablets have not been evaluated for the treatment of congestive heart failure or fluid retention due to renal or hepatic disease and the correct dosage for these conditions and other edema states has not been established. since a safe and effective diuretic dose has not been established, mykrox tablets should not be used when diuresis is desired. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy, and there is no evidence that they are useful in the treatment of developed toxemia (see precautions). edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. mykrox is not indicated for the treatment of edema in pregnancy. dependent edema in pregnancy resulting
zispin soltab 15 mg orodispersible tablets
merck sharp & dohme ireland (human health) limited - mirtazapine - orodispersible tablet - 15 milligram(s) - other antidepressants; mirtazapine
zispin soltab 30 mg orodispersible tablets
merck sharp & dohme ireland (human health) limited - mirtazapine - orodispersible tablet - 30 milligram(s) - other antidepressants; mirtazapine
triamterene and hydrochlorothiazide tablet
nucare pharmaceuticals,inc. - triamterene (unii: ws821z52lq) (triamterene - unii:ws821z52lq), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - this fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked. - triamterene and hydrochlorothiazide tablets are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone. - triamterene and hydrochlorothiazide is also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked (e.g., patients on concomitant digitalis preparations, or with a history of cardiac arryhthmias, etc.). triamterene and hydrochlorothiazide may be used alone or in combination with other antihypertensive drugs, such as beta-blockers. since triamterene and hydrochlorothiazide may enhance the actions of these drugs, dosage adjustments may be necessary. the routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent developme